Your browser doesn't support javascript.
loading
Seizure course of PCDH19 clustering epilepsy in female children: A multicentre cohort study in China.
Chen, Yi; Liu, Aijie; Zhang, Xiaoli; Ma, Xiuwei; Sun, Dan; Tian, Xiaojuan; Wu, Wenjuan; Zeng, Qi; Jiang, Yuwu; Zhang, Yuehua.
Affiliation
  • Chen Y; Department of Pediatrics, Peking University First Hospital, Beijing, China.
  • Liu A; Department of Pediatric Neurology, Capital Institute of Pediatrics, Beijing, China.
  • Zhang X; Department of Pediatrics, The Third Affiliated Hospital of Zheng Zhou University, Zhengzhou, China.
  • Ma X; Department of Neurology, Bayi Children's Hospital, General Military Hospital of Beijing, Beijing, China.
  • Sun D; Department of Neurology, Wuhan Children's Hospital, Wuhan, China.
  • Tian X; Department of Neurology, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing, China.
  • Wu W; Department of Neurology, Children's Hospital of Hebei Province, Shijiazhuang, China.
  • Zeng Q; Department of Neurology, Shenzhen Children's Hospital, Shenzhen, China.
  • Jiang Y; Department of Pediatrics, Peking University First Hospital, Beijing, China.
  • Zhang Y; Department of Pediatrics, Peking University First Hospital, Beijing, China.
Dev Med Child Neurol ; 2023 Nov 13.
Article in En | MEDLINE | ID: mdl-37960945
AIM: To investigate the seizure course of PCDH19 clustering epilepsy (PCDH19-CE) in a cohort of female children in China. METHOD: This ambidirectional cohort study examined 113 female patients with PCDH19-CE through multicentre collaboration. Prognostic factors for seizure freedom were evaluated by multivariate Cox regression analysis. RESULTS: The median seizure course period from seizure onset was 6 years 6 months. Of 113 patients, 78% and 56% experienced seizure freedom for at least 1 year and at least 2 years respectively. In patients younger than 5 years (n = 30), 5 to 10 years (n = 52), and older than 10 years (n = 31), 57%, 81%, and 94% experienced at least 1 year of seizure freedom, and 32%, 52%, and 84% experienced at least 2 years of seizure freedom, respectively. However, 58% (65 out of 113) relapsed at least once after more than 1 year of seizure freedom without trigger exposure (40%) or because of common triggers, including fever (43%) and antiseizure medication (ASM) reduction (29%). There was an 84% risk of seizure relapse after ASM reduction attempts. The likelihood of seizure freedom decreased with early age at seizure onset and developmental delay. INTERPRETATION: Patients with PCDH19-CE exhibit increasing seizure freedom with age, but there is a risk of relapse. ASM reduction in children younger than 10 years old requires caution. Patients with early seizure onset and developmental delay have a reduced chance of seizure freedom.

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Dev Med Child Neurol Year: 2023 Type: Article Affiliation country: China

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Dev Med Child Neurol Year: 2023 Type: Article Affiliation country: China